Taiwan seeks to attract global investors
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 23 Jul, 2013
Singapore: BioBusiness Asia concluded in Taiwan on July 18, 2013, with a message that the global biotech fraternity need...Read more
Singapore researchers get access to AstraZeneca drug compounds
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 04 Sep, 2015
Singapore: National Health Innovation Centre (NHIC) of Singapore has partnered with global pharmaceutical company, Astra...Read more
Chugai seeks approval for anti-cancer agent Avastin in Japan
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 25 Sep, 2012
Singapore: Japan's Chugai Pharmaceutical filed an application with the Japanese Ministry of Health, Labour and Welfare, ...Read more
A*STAR, Japanese bank ink partnership
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 20 Aug, 2014
Singapore: Singapore's Agency for Science, Technology and Research (A*STAR) and Japan's Sumitomo Mitsui Banking Corporat...Read more
Taiwan-China to collaborate on new drug discovery
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 05 Sep, 2014
Singapore: The Mainland Affairs Council (MAC) recently announced that Taiwan and China have reached a concrete consensus...Read more
Eliquis approved in EU for stroke prevention
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 21 Nov, 2012
Singapore: European Commission has approved Eliquis (apixaban) for prevention of stroke and systemic embolism in adult p...Read more
Lilly phase III lung cancer study meets endpoint
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 14 Aug, 2013
Singapore: Eli Lilly and Company completed its phase III study regarding stage IV metastatic squamous non-small cell lun...Read more
Dong-A Pharma gets positive trial results for Evogliptin
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 22 Jan, 2013
Singapore: South Korea's Dong-A Pharmaceutical announced positive top-line results from its phase II clinical trial of D...Read more
STA to commercialize leukemia drug in Australia
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 30 Jan, 2014
Singapore: US-based Ariad Pharmaceuticals has granted Specialised Therapeutics Australia (STA), a specialty pharmaceutic...Read more
Eisai, Santen enter agreement for new ophthalmic drugs
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 26 Sep, 2012
Singapore: Japan-based Eisai and Santen Pharmaceutical entered into an option agreement which grants Santen rights of ev...Read more
Takeda initiates Ph3 trial for Ixazomib in Asia
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 28 Jan, 2014
Singapore: Takeda Development Center Shanghai (TDC Shanghai) and Takeda Development Center Asia has commenced TOURMALINE...Read more
China plans to phase out mandatory cosmetics animal testing
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 11 Nov, 2013
Singapore: China's Food and Drug Administration plans to remove its mandatory animal test requirements for domestically ...Read more
Shimadzu launches i-series of HPLC system in Singapore
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 19 Aug, 2014
Singapore: Japan-based global analytics technology provider, Shimadzu (Asia Pacific), has launched i-Series of new indus...Read more
HUYA, Changzhou to harbour biotech innovation
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 19 Aug, 2014
Singapore: China's HUYA Bioscience has struck a partnership with Changzhou Center for Biotech Development (CZCBD) to foc...Read more
CSL progresses on Novartis influenza vaccine biz acquisition
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 31 Jul, 2015
Singapore: Australia based drug development company, CSL, has secured the necessary approvals required to proceed with t...Read more
Bionomics initiaties trial of anxiety drug in France
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 03 Feb, 2015
Singapore: Australia-based Bionomics has initiated a Phase 1b clinical trial in healthy volunteers of BNC210, the drug c...Read more
US FDA sets up task force for antibacterial drugs
Drug Discovery | Regulatory | By BioSpectrum Bureau | 0 Comment | 26 Sep, 2012
Singapore: The US Food and Drug Administration has formed an internal task force that will support the development of ne...Read more
Gilead buys liver disease drug candidate at $470 mn
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 07 Jan, 2015
Singapore: In a bid to boost drug pipeline, Gilead Sciences has acquired Farnesoid X Receptor (FXR) program comprising s...Read more